Despite its potential, targeting MRP1 presents several challenges:
Specificity: Achieving selective inhibition of MRP1 without affecting other ABC transporters is difficult. Toxicity: Inhibitors may cause unintended side effects by disrupting the normal physiological functions of MRP1. Resistance Mechanisms: Cancer cells can develop alternative resistance mechanisms, reducing the effectiveness of MRP1 inhibition.
